Skip to main content

Press shift tab to select search category

Loading...

Download the report
A conversation with David Loew

Press shift tab to select search category

Loading...
English EN Français FR EN
- English EN
- Français FR
Annual Report
< Back
- Global EN FR
- Annual Report EN FR
United States

Brazil

Canada

Mexico

Australia

China

Singapore

South Korea

Japan

Belgium

Ukraine

UK

Germany

France

Nordics

Greece

Italy

Netherlands

Spain

Poland

Russia

Czech Republic

Switzerland

Austria

UAE & Gulf

Country: Spain,Belgium,United States of America (the)

A study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in participants With Advanced Prostate Cancer

IPN price

€160.90

€-3.70 (-2.25%)

Download the report
Ipsen.com
Contact us

Terms and Conditions
Cookie Policy
Global Privacy Policy

© Ipsen Pharma. All rights reserved - 2026

You are now leaving the Ipsen group website. To continue, please click on Continue?